ネイティブコラーゲンのグローバル市場(2021〜2031):ウシ、ブタ、家禽、海産物、その他

■ 英語タイトル:Native Collagen Market By Source (Bovine, Porcine, Poultry, Marine, Others), By Application (Healthcare and Pharmaceuticals, Cosmetics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

調査会社Allied Market Research社が発行したリサーチレポート(データ管理コード:ALD23JN041)■ 発行会社/調査会社:Allied Market Research
■ 商品コード:ALD23JN041
■ 発行日:2022年9月
■ 調査対象地域:グローバル
■ 産業分野:化学
■ ページ数:330
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後24時間以内)
■ 販売価格オプション(消費税別)
Online Only(1名閲覧、印刷不可)USD3,570 ⇒換算¥542,640見積依頼/購入/質問フォーム
Single User(1名閲覧)USD5,730 ⇒換算¥870,960見積依頼/購入/質問フォーム
Enterprise User(閲覧人数無制限)USD9,600 ⇒換算¥1,459,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
Allied Market Research社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[ネイティブコラーゲンのグローバル市場(2021〜2031):ウシ、ブタ、家禽、海産物、その他]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

Allied Market Research社の本調査資料では、2021年に305.2百万ドルであった世界のネイティブコラーゲン市場規模が、2031年までに555.1百万ドルに到達し、2022年から2031年の間に年平均6.2%で拡大すると予測しています。本資料は、ネイティブコラーゲンの世界市場について総合的に調査・分析を行い、イントロダクション、エグゼクティブサマリー、市場概要、由来別(ウシ、ブタ、家禽、海産物、その他)分析、用途別(医療・医薬品、化粧品、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米・中東・アフリカ)分析、企業状況、企業情報などの項目を以下の構成でまとめております。本資料は、Creative Enzymes、Symatese、Vetoquinol S.A.、Bio-Rad Laboratories, Inc.、REPROCELL USA Inc.、Aviva Systems Biology Corporation、RayBiotech, Inc.などの企業情報を含んでいます。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・世界のネイティブコラーゲン市場規模:由来別
-ウシ由来ネイティブコラーゲンの市場規模
-ブタ由来ネイティブコラーゲンの市場規模
-家禽由来ネイティブコラーゲンの市場規模
-海産物由来ネイティブコラーゲンの市場規模
-その他の市場規模
・世界のネイティブコラーゲン市場規模:用途別
-医療・医薬品における市場規模
-化粧品における市場規模
-その他における市場規模
・世界のネイティブコラーゲン市場規模:地域別
- 北米のネイティブコラーゲン市場規模
- ヨーロッパのネイティブコラーゲン市場規模
- アジア太平洋のネイティブコラーゲン市場規模
- 中南米・中東・アフリカのネイティブコラーゲン市場規模
・企業状況
・企業情報

世界のネイティブコラーゲン市場規模は、2021年に3億520万ドルと評価され、2022年から2031年までの年平均成長率は6.2%となり、2031年には5億5510万ドルに達すると予測されています。
コラーゲンは、医療、化粧品、食品・飲料などの様々な産業用途に広く使用することができる汎用性の高い特性を持っています。したがって、医薬品および化粧品業界におけるコラーゲンの用途の増加は、コラーゲン製品の需要を促進すると予想されます。化粧品用途は2021年の市場シェアの24%以上を占めています。

コラーゲンは、基本的な構造を支える動物性生物に見られる構造タンパク質です。最も一般的には、哺乳類や魚類の皮膚から抽出されます。コラーゲンは、天然の保湿剤や皮膚の保湿剤など、その興味深い特性により、化粧品業界だけでなく、学術的にも大きな関心を集めています。コラーゲンを主成分とするヘアケア製品は、薄毛を改善し、日焼けによるダメージから髪を守ります。さらに、髪の成長を促進し、頭皮の保湿を高めます。ネイティブコラーゲン市場のプレーヤーは、革新的な製品を開発するために継続的な研究開発活動に取り組んでいます。例えば、COBIOSAはヘアケアやスキンケア用に海洋性コラーゲンを生産しています。

中国の高齢化は、現代史におけるほぼすべての国よりも急速に進んでいます。2020年に発表された国勢調査によると、中国の人口の18.7%が60歳で、65歳以上は13.5%を占めています。2050年には、定年退職者以上の人口が全人口の39%を占めると推定されています。インドでは、国家人口委員会の報告によると、2021年には1億3,800万人近くの高齢者がインドに住んでいると推定されています。このように、高齢者人口の増加率は一般人口よりも高いのです。発展途上国では、栄養ケアやヘルスケア製品を必要とする高齢者の存在が、ネイティブコラーゲンの需要を高めています。この地域に住む人々の間で、高齢化する人々に対するネイティブコラーゲンの重要性に関する認識が徐々に高まっていることが、市場の需要を促進するでしょう。加えて、ネイティブコラーゲン製品に関する人々の認識不足が、この地域における市場の発展を妨げています。さらに、ライフスタイルの急速な変化や中間層の一人当たり所得の増加も、市場にプラスの影響を与えるでしょう。

ライフスタイルや食習慣の変化、西洋的な食習慣の採用、食品における機能性成分の需要の増加、プロセス強化の必要性につながる産業活動の増加が、新興国におけるコラーゲン市場の発展に寄与しています。アジア太平洋、南アフリカ、中東、南米、東欧諸国などの新興国は、市場の成長に絶好の機会を提供しています。

世界のネイティブコラーゲン市場は、原料、用途、地域によって区分されます。原料別では、牛、豚、家禽、海洋、その他に区分されます。用途別では、ヘルスケア・医薬品、化粧品、その他に区分されます。さらに、ヘルスケア・医薬品分野は、骨・関節再建、創傷被覆、組織再生、その他にさらに二分されます。地域別では、北米、欧州、アジア太平洋、LAMEAに市場を分けて分析しています。現在のところ、北米が市場の最大シェアを占めており、次いでアジア太平洋、欧州となっています。

本レポートに掲載されている主要企業には、Aviva Systems Biology Corporation、Beyond Biopharma Co.Ltd.、Bioiberica S.A.U.、Bio-Rad Laboratories, Inc.、Cosmo Bio、Creative Enzymes、RayBiotech, Inc.、REPROCELL Inc.、Rockland Immunochemicals Incなどがあります。生産能力の拡大、買収、提携、抽出技術の研究と革新などの追加成長戦略は、世界のネイティブコラーゲン市場動向の主要な開発を達成するためにつながっています。

COVID-19が世界のネイティブコラーゲン市場に与える影響
世界的なCOVID-19の流行は、ネイティブコラーゲン市場にマイナスの影響を与えています。この市場は、パンデミック前の水準と比較して、すべての地域で需要が予想を下回っています。世界市場は、様々な食品加工産業や生産原料として使用される農業活動の停止により、2019年と比較して2020年には約25%の減少を示しました。

複数の健康上の利点を提供する栄養価の高い製品への需要が増加。コラーゲンは、高齢化社会をターゲットとしたサプリメントに広く使用されています。高齢化人口によるコラーゲンベースのサプリメントの需要は、健康、免疫力、総合的なウェルネスを高めると予想されています。さらに、パンデミックによる健康懸念の高まりにより、消費者は食品や飲料の製品ラベルに注目するようになりました。これは、医薬品とヘルスケア製品に十分な機会を提供すると予測されます。パンデミックの発生は、輸送の制限や労働者の不足により、コラーゲン製造の日常業務に影響を及ぼすと予測されています。しかし、パンデミックは、食品、飲料、栄養製品など、コラーゲンが使用されるさまざまな最終製品の健康志向の消費者の注目を集めるため、調査期間中にコラーゲンの売上を押し上げると予想されます。

パンデミック危機以降、大手コラーゲンメーカーは、化粧品、医薬品、ヘルスケア、その他の分野において、ネイティブコラーゲンに関連する様々な製品の開発に投資しています。さらに、パンデミックの発生により、高齢者向けのネイティブコラーゲンの利点に対する認識が高まったことが需要の増加につながり、予測期間中の市場にプラスの影響を与えるでしょう。

〈ステークホルダーにとっての主なメリット〉
・本レポートは、2021年から2031年までのネイティブコラーゲン市場分析の市場セグメント、現在の動向、予測、ダイナミクスを定量的に分析し、ネイティブコラーゲン市場の優勢な機会を特定します。
・主要な促進要因、阻害要因、機会に関する情報とともに市場調査を提供します。
・ポーターのファイブフォース分析により、バイヤーとサプライヤーの潜在力を明らかにし、ステークホルダーが利益重視のビジネス決定を下し、サプライヤーとバイヤーのネットワークを強化できるようにします。
・ネイティブコラーゲン市場のセグメンテーションを詳細に分析することで、市場機会を見極めることができます。
・各地域の主要国を世界市場への収益貢献度に応じてマッピングしています。
・市場プレイヤーのポジショニングはベンチマーキングを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。
・地域別および世界のネイティブコラーゲン市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析を含みます。

〈主要市場セグメント〉
原料別


家禽
海洋
その他

用途別
ヘルスケア・医薬品
化粧品
その他

地域別
・北米
米国
カナダ
メキシコ
・ヨーロッパ
スペイン
その他のヨーロッパ
ドイツ
フランス
イタリア
・アジア太平洋
中国
日本
インド
韓国
その他のアジア太平洋地域
・LAMEA
ラテンアメリカ
アフリカ
中東

〈主要市場プレイヤー〉
Creative Enzymes
Symatese
Vetoquinol S.A.
Bio-Rad Laboratories, Inc.
REPROCELL USA Inc.
Aviva Systems Biology Corporation
RayBiotech, Inc.
Cosmo Bio
Bioiberica S.A.U
Rockland Immunochemicals Inc.
Beyond Biopharma Co., Ltd.
TSI GROUP

世界の市場調査レポート販売サイト(H&Iグローバルリサーチ株式会社運営)
*** レポート目次(コンテンツ)***

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
3.7.Pricing Analysis
3.8.Value Chain Analysis
3.9.Key Regulation Analysis
CHAPTER 4: NATIVE COLLAGEN MARKET, BY SOURCE
4.1 Overview
4.1.1 Market size and forecast
4.2 Bovine
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Porcine
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Poultry
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Marine
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
4.6 Others
4.6.1 Key market trends, growth factors and opportunities
4.6.2 Market size and forecast, by region
4.6.3 Market analysis by country
CHAPTER 5: NATIVE COLLAGEN MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Healthcare and Pharmaceuticals
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.2.4 Healthcare and Pharmaceuticals Native Collagen Market by End Use
5.2.4.1 Bone and Joint Reconstruction Market size and forecast, by region
5.2.4.2 Bone and Joint Reconstruction Market size and forecast, by country
5.2.4.3 Wound Dressing Market size and forecast, by region
5.2.4.4 Wound Dressing Market size and forecast, by country
5.2.4.5 Tissue Regeneration Market size and forecast, by region
5.2.4.6 Tissue Regeneration Market size and forecast, by country
5.2.4.7 Others Market size and forecast, by region
5.2.4.8 Others Market size and forecast, by country
5.3 Cosmetics
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Others
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
CHAPTER 6: NATIVE COLLAGEN MARKET, BY REGION
6.1 Overview
6.1.1 Market size and forecast
6.2 North America
6.2.1 Key trends and opportunities
6.2.2 North America Market size and forecast, by Source
6.2.3 North America Market size and forecast, by Application
6.2.3.1 North America Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.2.4 North America Market size and forecast, by country
6.2.4.1 U.S.
6.2.4.1.1 Market size and forecast, by Source
6.2.4.1.2 Market size and forecast, by Application
6.2.4.1.2.1 U.S. Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.2.4.2 Canada
6.2.4.2.1 Market size and forecast, by Source
6.2.4.2.2 Market size and forecast, by Application
6.2.4.2.2.1 Canada Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.2.4.3 Mexico
6.2.4.3.1 Market size and forecast, by Source
6.2.4.3.2 Market size and forecast, by Application
6.2.4.3.2.1 Mexico Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.3 Europe
6.3.1 Key trends and opportunities
6.3.2 Europe Market size and forecast, by Source
6.3.3 Europe Market size and forecast, by Application
6.3.3.1 Europe Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.3.4 Europe Market size and forecast, by country
6.3.4.1 Germany
6.3.4.1.1 Market size and forecast, by Source
6.3.4.1.2 Market size and forecast, by Application
6.3.4.1.2.1 Germany Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.3.4.2 France
6.3.4.2.1 Market size and forecast, by Source
6.3.4.2.2 Market size and forecast, by Application
6.3.4.2.2.1 France Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.3.4.3 Italy
6.3.4.3.1 Market size and forecast, by Source
6.3.4.3.2 Market size and forecast, by Application
6.3.4.3.2.1 Italy Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.3.4.4 Spain
6.3.4.4.1 Market size and forecast, by Source
6.3.4.4.2 Market size and forecast, by Application
6.3.4.4.2.1 Spain Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.3.4.5 Rest of Europe
6.3.4.5.1 Market size and forecast, by Source
6.3.4.5.2 Market size and forecast, by Application
6.3.4.5.2.1 Rest of Europe Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.4 Asia-Pacific
6.4.1 Key trends and opportunities
6.4.2 Asia-Pacific Market size and forecast, by Source
6.4.3 Asia-Pacific Market size and forecast, by Application
6.4.3.1 Asia-Pacific Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.4.4 Asia-Pacific Market size and forecast, by country
6.4.4.1 China
6.4.4.1.1 Market size and forecast, by Source
6.4.4.1.2 Market size and forecast, by Application
6.4.4.1.2.1 China Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.4.4.2 Japan
6.4.4.2.1 Market size and forecast, by Source
6.4.4.2.2 Market size and forecast, by Application
6.4.4.2.2.1 Japan Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.4.4.3 India
6.4.4.3.1 Market size and forecast, by Source
6.4.4.3.2 Market size and forecast, by Application
6.4.4.3.2.1 India Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.4.4.4 South Korea
6.4.4.4.1 Market size and forecast, by Source
6.4.4.4.2 Market size and forecast, by Application
6.4.4.4.2.1 South Korea Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.4.4.5 Rest of Asia-Pacific
6.4.4.5.1 Market size and forecast, by Source
6.4.4.5.2 Market size and forecast, by Application
6.4.4.5.2.1 Rest of Asia-Pacific Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.5 LAMEA
6.5.1 Key trends and opportunities
6.5.2 LAMEA Market size and forecast, by Source
6.5.3 LAMEA Market size and forecast, by Application
6.5.3.1 LAMEA Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.5.4 LAMEA Market size and forecast, by country
6.5.4.1 Latin America
6.5.4.1.1 Market size and forecast, by Source
6.5.4.1.2 Market size and forecast, by Application
6.5.4.1.2.1 Latin America Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.5.4.2 Africa
6.5.4.2.1 Market size and forecast, by Source
6.5.4.2.2 Market size and forecast, by Application
6.5.4.2.2.1 Africa Healthcare and Pharmaceuticals Native Collagen Market by End Use
6.5.4.3 Middle East
6.5.4.3.1 Market size and forecast, by Source
6.5.4.3.2 Market size and forecast, by Application
6.5.4.3.2.1 Middle East Healthcare and Pharmaceuticals Native Collagen Market by End Use
CHAPTER 7: COMPANY LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Key developments
CHAPTER 8: COMPANY PROFILES
8.1 Creative Enzymes
8.1.1 Company overview
8.1.2 Company snapshot
8.1.3 Operating business segments
8.1.4 Product portfolio
8.1.5 Business performance
8.1.6 Key strategic moves and developments
8.2 Symatese
8.2.1 Company overview
8.2.2 Company snapshot
8.2.3 Operating business segments
8.2.4 Product portfolio
8.2.5 Business performance
8.2.6 Key strategic moves and developments
8.3 Vetoquinol S.A.
8.3.1 Company overview
8.3.2 Company snapshot
8.3.3 Operating business segments
8.3.4 Product portfolio
8.3.5 Business performance
8.3.6 Key strategic moves and developments
8.4 Bio-Rad Laboratories, Inc.
8.4.1 Company overview
8.4.2 Company snapshot
8.4.3 Operating business segments
8.4.4 Product portfolio
8.4.5 Business performance
8.4.6 Key strategic moves and developments
8.5 REPROCELL USA Inc.
8.5.1 Company overview
8.5.2 Company snapshot
8.5.3 Operating business segments
8.5.4 Product portfolio
8.5.5 Business performance
8.5.6 Key strategic moves and developments
8.6 Aviva Systems Biology Corporation
8.6.1 Company overview
8.6.2 Company snapshot
8.6.3 Operating business segments
8.6.4 Product portfolio
8.6.5 Business performance
8.6.6 Key strategic moves and developments
8.7 RayBiotech, Inc.
8.7.1 Company overview
8.7.2 Company snapshot
8.7.3 Operating business segments
8.7.4 Product portfolio
8.7.5 Business performance
8.7.6 Key strategic moves and developments
8.8 Cosmo Bio
8.8.1 Company overview
8.8.2 Company snapshot
8.8.3 Operating business segments
8.8.4 Product portfolio
8.8.5 Business performance
8.8.6 Key strategic moves and developments
8.9 Bioiberica S.A.U
8.9.1 Company overview
8.9.2 Company snapshot
8.9.3 Operating business segments
8.9.4 Product portfolio
8.9.5 Business performance
8.9.6 Key strategic moves and developments
8.10 Rockland Immunochemicals Inc.
8.10.1 Company overview
8.10.2 Company snapshot
8.10.3 Operating business segments
8.10.4 Product portfolio
8.10.5 Business performance
8.10.6 Key strategic moves and developments
8.11 Beyond Biopharma Co., Ltd.
8.11.1 Company overview
8.11.2 Company snapshot
8.11.3 Operating business segments
8.11.4 Product portfolio
8.11.5 Business performance
8.11.6 Key strategic moves and developments
8.12 TSI GROUP
8.12.1 Company overview
8.12.2 Company snapshot
8.12.3 Operating business segments
8.12.4 Product portfolio
8.12.5 Business performance
8.12.6 Key strategic moves and developments

LIST OF TABLES
TABLE 1. GLOBAL NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 2. GLOBAL NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 3. NATIVE COLLAGEN MARKET, FOR BOVINE, BY REGION, 2021-2031 ($MILLION)
TABLE 4. NATIVE COLLAGEN MARKET, FOR BOVINE, BY REGION, 2021-2031 (TONS)
TABLE 5. NATIVE COLLAGEN MARKET FOR BOVINE, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 6. NATIVE COLLAGEN MARKET FOR BOVINE, BY COUNTRY, 2021-2031 (TONS)
TABLE 7. NATIVE COLLAGEN MARKET, FOR PORCINE, BY REGION, 2021-2031 ($MILLION)
TABLE 8. NATIVE COLLAGEN MARKET, FOR PORCINE, BY REGION, 2021-2031 (TONS)
TABLE 9. NATIVE COLLAGEN MARKET FOR PORCINE, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 10. NATIVE COLLAGEN MARKET FOR PORCINE, BY COUNTRY, 2021-2031 (TONS)
TABLE 11. NATIVE COLLAGEN MARKET, FOR POULTRY, BY REGION, 2021-2031 ($MILLION)
TABLE 12. NATIVE COLLAGEN MARKET, FOR POULTRY, BY REGION, 2021-2031 (TONS)
TABLE 13. NATIVE COLLAGEN MARKET FOR POULTRY, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 14. NATIVE COLLAGEN MARKET FOR POULTRY, BY COUNTRY, 2021-2031 (TONS)
TABLE 15. NATIVE COLLAGEN MARKET, FOR MARINE, BY REGION, 2021-2031 ($MILLION)
TABLE 16. NATIVE COLLAGEN MARKET, FOR MARINE, BY REGION, 2021-2031 (TONS)
TABLE 17. NATIVE COLLAGEN MARKET FOR MARINE, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 18. NATIVE COLLAGEN MARKET FOR MARINE, BY COUNTRY, 2021-2031 (TONS)
TABLE 19. NATIVE COLLAGEN MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 20. NATIVE COLLAGEN MARKET, FOR OTHERS, BY REGION, 2021-2031 (TONS)
TABLE 21. NATIVE COLLAGEN MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 22. NATIVE COLLAGEN MARKET FOR OTHERS, BY COUNTRY, 2021-2031 (TONS)
TABLE 23. GLOBAL NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 24. GLOBAL NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 25. NATIVE COLLAGEN MARKET, FOR HEALTHCARE AND PHARMACEUTICALS, BY REGION, 2021-2031 ($MILLION)
TABLE 26. NATIVE COLLAGEN MARKET, FOR HEALTHCARE AND PHARMACEUTICALS, BY REGION, 2021-2031 (TONS)
TABLE 27. NATIVE COLLAGEN MARKET FOR HEALTHCARE AND PHARMACEUTICALS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 28. NATIVE COLLAGEN MARKET FOR HEALTHCARE AND PHARMACEUTICALS, BY COUNTRY, 2021-2031 (TONS)
TABLE 29. GLOBAL HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 30. GLOBAL HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 31. NATIVE COLLAGEN MARKET, FOR BONE AND JOINT RECONSTRUCTION, BY REGION, 2021-2031 ($MILLION)
TABLE 32. NATIVE COLLAGEN MARKET, FOR BONE AND JOINT RECONSTRUCTION, BY REGION, 2021-2031 (TONS)
TABLE 33. NATIVE COLLAGEN MARKET, FOR BONE AND JOINT RECONSTRUCTION, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 34. NATIVE COLLAGEN MARKET, FOR BONE AND JOINT RECONSTRUCTION, BY COUNTRY, 2021-2031 (TONS)
TABLE 35. NATIVE COLLAGEN MARKET, FOR WOUND DRESSING, BY REGION, 2021-2031 ($MILLION)
TABLE 36. NATIVE COLLAGEN MARKET, FOR WOUND DRESSING, BY REGION, 2021-2031 (TONS)
TABLE 37. NATIVE COLLAGEN MARKET, FOR WOUND DRESSING, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 38. NATIVE COLLAGEN MARKET, FOR WOUND DRESSING, BY COUNTRY, 2021-2031 (TONS)
TABLE 39. NATIVE COLLAGEN MARKET, FOR TISSUE REGENERATION, BY REGION, 2021-2031 ($MILLION)
TABLE 40. NATIVE COLLAGEN MARKET, FOR TISSUE REGENERATION, BY REGION, 2021-2031 (TONS)
TABLE 41. NATIVE COLLAGEN MARKET, FOR TISSUE REGENERATION, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 42. NATIVE COLLAGEN MARKET, FOR TISSUE REGENERATION, BY COUNTRY, 2021-2031 (TONS)
TABLE 43. NATIVE COLLAGEN MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 44. NATIVE COLLAGEN MARKET, FOR OTHERS, BY REGION, 2021-2031 (TONS)
TABLE 45. NATIVE COLLAGEN MARKET, FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 46. NATIVE COLLAGEN MARKET, FOR OTHERS, BY COUNTRY, 2021-2031 (TONS)
TABLE 47. NATIVE COLLAGEN MARKET, FOR COSMETICS, BY REGION, 2021-2031 ($MILLION)
TABLE 48. NATIVE COLLAGEN MARKET, FOR COSMETICS, BY REGION, 2021-2031 (TONS)
TABLE 49. NATIVE COLLAGEN MARKET FOR COSMETICS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 50. NATIVE COLLAGEN MARKET FOR COSMETICS, BY COUNTRY, 2021-2031 (TONS)
TABLE 51. NATIVE COLLAGEN MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 52. NATIVE COLLAGEN MARKET, FOR OTHERS, BY REGION, 2021-2031 (TONS)
TABLE 53. NATIVE COLLAGEN MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 54. NATIVE COLLAGEN MARKET FOR OTHERS, BY COUNTRY, 2021-2031 (TONS)
TABLE 55. NATIVE COLLAGEN MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 56. NATIVE COLLAGEN MARKET, BY REGION, 2021-2031 (TONS)
TABLE 57. NORTH AMERICA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 58. NORTH AMERICA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 59. NORTH AMERICA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 60. NORTH AMERICA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 61. NORTH AMERICA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 62. NORTH AMERICA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 63. NORTH AMERICA NATIVE COLLAGEN MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 64. NORTH AMERICA NATIVE COLLAGEN MARKET, BY COUNTRY, 2021-2031 (TONS)
TABLE 65. U.S. NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 66. U.S. NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 67. U.S. NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 68. U.S. NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 69. U.S. HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 70. U.S. HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 71. CANADA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 72. CANADA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 73. CANADA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 74. CANADA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 75. CANADA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 76. CANADA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 77. MEXICO NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 78. MEXICO NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 79. MEXICO NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 80. MEXICO NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 81. MEXICO HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 82. MEXICO HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 83. EUROPE NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 84. EUROPE NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 85. EUROPE NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 86. EUROPE NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 87. EUROPE HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 88. EUROPE HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 89. EUROPE NATIVE COLLAGEN MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 90. EUROPE NATIVE COLLAGEN MARKET, BY COUNTRY, 2021-2031 (TONS)
TABLE 91. GERMANY NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 92. GERMANY NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 93. GERMANY NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 94. GERMANY NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 95. GERMANY HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 96. GERMANY HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 97. FRANCE NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 98. FRANCE NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 99. FRANCE NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 100. FRANCE NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 101. FRANCE HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 102. FRANCE HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 103. ITALY NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 104. ITALY NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 105. ITALY NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 106. ITALY NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 107. ITALY HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 108. ITALY HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 109. SPAIN NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 110. SPAIN NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 111. SPAIN NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 112. SPAIN NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 113. SPAIN HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 114. SPAIN HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 115. REST OF EUROPE NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 116. REST OF EUROPE NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 117. REST OF EUROPE NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 118. REST OF EUROPE NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 119. REST OF EUROPE HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 120. REST OF EUROPE HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 121. ASIA-PACIFIC NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 122. ASIA-PACIFIC NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 123. ASIA-PACIFIC NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 124. ASIA-PACIFIC NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 125. ASIA-PACIFIC HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 126. ASIA-PACIFIC HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 127. ASIA-PACIFIC NATIVE COLLAGEN MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 128. ASIA-PACIFIC NATIVE COLLAGEN MARKET, BY COUNTRY, 2021-2031 (TONS)
TABLE 129. CHINA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 130. CHINA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 131. CHINA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 132. CHINA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 133. CHINA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 134. CHINA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 135. JAPAN NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 136. JAPAN NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 137. JAPAN NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 138. JAPAN NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 139. JAPAN HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 140. JAPAN HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 141. INDIA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 142. INDIA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 143. INDIA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 144. INDIA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 145. INDIA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 146. INDIA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 147. SOUTH KOREA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 148. SOUTH KOREA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 149. SOUTH KOREA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 150. SOUTH KOREA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 151. SOUTH KOREA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 152. SOUTH KOREA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 153. REST OF ASIA-PACIFIC NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 154. REST OF ASIA-PACIFIC NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 155. REST OF ASIA-PACIFIC NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 156. REST OF ASIA-PACIFIC NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 157. REST OF ASIA-PACIFIC HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 158. REST OF ASIA-PACIFIC HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 159. LAMEA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 160. LAMEA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 161. LAMEA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 162. LAMEA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 163. LAMEA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 164. LAMEA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 165. LAMEA NATIVE COLLAGEN MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 166. LAMEA NATIVE COLLAGEN MARKET, BY COUNTRY, 2021-2031 (TONS)
TABLE 167. LATIN AMERICA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 168. LATIN AMERICA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 169. LATIN AMERICA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 170. LATIN AMERICA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 171. LATIN AMERICA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 172. LATIN AMERICA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 173. AFRICA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 174. AFRICA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 175. AFRICA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 176. AFRICA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 177. AFRICA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 178. AFRICA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 179. MIDDLE EAST NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 180. MIDDLE EAST NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
TABLE 181. MIDDLE EAST NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 182. MIDDLE EAST NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
TABLE 183. MIDDLE EAST HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 184. MIDDLE EAST HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
TABLE 185.CREATIVE ENZYMES: COMPANY SNAPSHOT
TABLE 186.CREATIVE ENZYMES: OPERATING SEGMENTS
TABLE 187.CREATIVE ENZYMES: PRODUCT PORTFOLIO
TABLE 188.CREATIVE ENZYMES: NET SALES,
TABLE 189.CREATIVE ENZYMES: KEY STRATERGIES
TABLE 190.SYMATESE: COMPANY SNAPSHOT
TABLE 191.SYMATESE: OPERATING SEGMENTS
TABLE 192.SYMATESE: PRODUCT PORTFOLIO
TABLE 193.SYMATESE: NET SALES,
TABLE 194.SYMATESE: KEY STRATERGIES
TABLE 195.VETOQUINOL S.A.: COMPANY SNAPSHOT
TABLE 196.VETOQUINOL S.A.: OPERATING SEGMENTS
TABLE 197.VETOQUINOL S.A.: PRODUCT PORTFOLIO
TABLE 198.VETOQUINOL S.A.: NET SALES,
TABLE 199.VETOQUINOL S.A.: KEY STRATERGIES
TABLE 200.BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
TABLE 201.BIO-RAD LABORATORIES, INC.: OPERATING SEGMENTS
TABLE 202.BIO-RAD LABORATORIES, INC.: PRODUCT PORTFOLIO
TABLE 203.BIO-RAD LABORATORIES, INC.: NET SALES,
TABLE 204.BIO-RAD LABORATORIES, INC.: KEY STRATERGIES
TABLE 205.REPROCELL USA INC.: COMPANY SNAPSHOT
TABLE 206.REPROCELL USA INC.: OPERATING SEGMENTS
TABLE 207.REPROCELL USA INC.: PRODUCT PORTFOLIO
TABLE 208.REPROCELL USA INC.: NET SALES,
TABLE 209.REPROCELL USA INC.: KEY STRATERGIES
TABLE 210.AVIVA SYSTEMS BIOLOGY CORPORATION: COMPANY SNAPSHOT
TABLE 211.AVIVA SYSTEMS BIOLOGY CORPORATION: OPERATING SEGMENTS
TABLE 212.AVIVA SYSTEMS BIOLOGY CORPORATION: PRODUCT PORTFOLIO
TABLE 213.AVIVA SYSTEMS BIOLOGY CORPORATION: NET SALES,
TABLE 214.AVIVA SYSTEMS BIOLOGY CORPORATION: KEY STRATERGIES
TABLE 215.RAYBIOTECH, INC.: COMPANY SNAPSHOT
TABLE 216.RAYBIOTECH, INC.: OPERATING SEGMENTS
TABLE 217.RAYBIOTECH, INC.: PRODUCT PORTFOLIO
TABLE 218.RAYBIOTECH, INC.: NET SALES,
TABLE 219.RAYBIOTECH, INC.: KEY STRATERGIES
TABLE 220.COSMO BIO: COMPANY SNAPSHOT
TABLE 221.COSMO BIO: OPERATING SEGMENTS
TABLE 222.COSMO BIO: PRODUCT PORTFOLIO
TABLE 223.COSMO BIO: NET SALES,
TABLE 224.COSMO BIO: KEY STRATERGIES
TABLE 225.BIOIBERICA S.A.U: COMPANY SNAPSHOT
TABLE 226.BIOIBERICA S.A.U: OPERATING SEGMENTS
TABLE 227.BIOIBERICA S.A.U: PRODUCT PORTFOLIO
TABLE 228.BIOIBERICA S.A.U: NET SALES,
TABLE 229.BIOIBERICA S.A.U: KEY STRATERGIES
TABLE 230.ROCKLAND IMMUNOCHEMICALS INC.: COMPANY SNAPSHOT
TABLE 231.ROCKLAND IMMUNOCHEMICALS INC.: OPERATING SEGMENTS
TABLE 232.ROCKLAND IMMUNOCHEMICALS INC.: PRODUCT PORTFOLIO
TABLE 233.ROCKLAND IMMUNOCHEMICALS INC.: NET SALES,
TABLE 234.ROCKLAND IMMUNOCHEMICALS INC.: KEY STRATERGIES
TABLE 235.BEYOND BIOPHARMA CO., LTD.: COMPANY SNAPSHOT
TABLE 236.BEYOND BIOPHARMA CO., LTD.: OPERATING SEGMENTS
TABLE 237.BEYOND BIOPHARMA CO., LTD.: PRODUCT PORTFOLIO
TABLE 238.BEYOND BIOPHARMA CO., LTD.: NET SALES,
TABLE 239.BEYOND BIOPHARMA CO., LTD.: KEY STRATERGIES
TABLE 240.TSI GROUP: COMPANY SNAPSHOT
TABLE 241.TSI GROUP: OPERATING SEGMENTS
TABLE 242.TSI GROUP: PRODUCT PORTFOLIO
TABLE 243.TSI GROUP: NET SALES,
TABLE 244.TSI GROUP: KEY STRATERGIES

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(ALD23JN041 )"ネイティブコラーゲンのグローバル市場(2021〜2031):ウシ、ブタ、家禽、海産物、その他" (英文:Native Collagen Market By Source (Bovine, Porcine, Poultry, Marine, Others), By Application (Healthcare and Pharmaceuticals, Cosmetics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031)はAllied Market Research社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。